Abstract
Hemotherapy in developed countries is safer than ever but the present perception of
society seems different than in the past. As Isbister wrote, during recent years,
as blood safety has been progressively improved, the legal risks have been increasing.
The first task is to study and define the risks for each activity. For me the management
of risks may be achieved through the management of quality. The confidence of society
in blood transfusion can probably best be obtained through a kind of recognised external
quality assurance.
I intend to describe our targets, our difficulties and the factors that have made
our certification a success. I shall focus on several points:
- •what quality represents;
- •what our haemapheresis service is;
- •what ISO 9002 standards are and why we choose them;
- •our difficulties and the factors of success.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Transfusion and Apheresis ScienceAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Accepted:
November 1,
1998
Received:
September 11,
1998
Identification
Copyright
© 1999 Published by Elsevier Inc.
